Cisplatin nephrotoxicity in male beagle dogs: next-generation protein kidney safety biomarker tissue expression and related changes in urine
Author(s) -
J. Eric McDuffie,
Y. Chen,
J. Y.,
S. Lee,
Karen Lynch,
D. M. Hamlin,
Linh T. Nguyen,
Michèle Rizzolio,
Manisha Sonee,
Sandra S. Snook
Publication year - 2016
Publication title -
toxicology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.709
H-Index - 31
eISSN - 2045-4538
pISSN - 2045-452X
DOI - 10.1039/c5tx00497g
Subject(s) - clusterin , beagle , urine , medicine , nephrotoxicity , biomarker , kidney , urinary system , cisplatin , pathology , lipocalin , staining , urology , apoptosis , biology , chemotherapy , biochemistry
In dogs, CDDP induced corticomedullary tubular lesions [A.]; clusterin (CLU) staining in damaged medullary tubules [B.]; and elevated urinary CLU [C.]. Baseline CLU was detected from Control dogs [A. and C.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom